Page 89 - Contracting Command News Today : Breaking News, Live Updates & Top Stories | Vimarsana

-Positive Efficacy Signals from Trials of Prevention and Treatment of COVID-19 Improvement of Respiratory Symptoms and Fewer Intensive Care Admissions from Previously Reported Trial in Patients with COVID-19 Potential Activity Against All SARS-CoV-2 Variants-HOUSTON (BUSINESS WIRE) #biotech Pulmotect, Inc., a c.

New jerseyUnited statesUs department of defensePulmotect incNational institutes of healthWorld health organizationProgram executive office for chemicalUs army contractingNuclear defenseDefense consortiumResearch institute of texasPositive efficacy signalsRespiratory symptomsFewer intensive care admissionsPreviously reported trialPotential activity against all